HomeCompareTLIS vs STAG

TLIS vs STAG: Dividend Comparison 2026

TLIS yields 70.42% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TLIS wins by $1.05M in total portfolio value
10 years
TLIS
TLIS
● Live price
70.42%
Share price
$2.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.07M
Annual income
$282,657.96
Full TLIS calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.09
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.22
Full STAG calculator →

Portfolio growth — TLIS vs STAG

📍 TLIS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTLISSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TLIS + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TLIS pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TLIS
Annual income on $10K today (after 15% tax)
$5,985.92/yr
After 10yr DRIP, annual income (after tax)
$240,259.27/yr
STAG
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$392.89/yr
At 15% tax rate, TLIS beats the other by $239,866.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TLIS + STAG for your $10,000?

TLIS: 50%STAG: 50%
100% STAG50/50100% TLIS
Portfolio after 10yr
$545.3K
Annual income
$141,560.09/yr
Blended yield
25.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

TLIS
Analyst Ratings
1
Hold
3
Sell
Consensus: Sell
Altman Z
-12.3
Piotroski
1/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.7% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TLIS buys
0
STAG buys
0
No recent congressional trades found for TLIS or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTLISSTAG
Forward yield70.42%3.44%
Annual dividend / share$2.00$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3%
Portfolio after 10y$1.07M$18.3K
Annual income after 10y$282,657.96$462.22
Total dividends collected$914.3K$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusSellBuy

Year-by-year: TLIS vs STAG ($10,000, DRIP)

YearTLIS PortfolioTLIS Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$17,742$7,042.25$10,665$345.09+$7.1KTLIS
2$30,661$11,677.14$11,364$357.70+$19.3KTLIS
3$51,667$18,859.73$12,098$370.43+$39.6KTLIS
4$84,985$29,701.39$12,869$383.28+$72.1KTLIS
5$136,593$45,658.47$13,677$396.23+$122.9KTLIS
6$214,738$68,583.71$14,524$409.27+$200.2KTLIS
7$330,537$100,766.97$15,411$422.41+$315.1KTLIS
8$498,633$144,958.95$16,339$435.61+$482.3KTLIS
9$737,910$204,372.63$17,311$448.89+$720.6KTLIS
10$1,072,222$282,657.96$18,327$462.22+$1.05MTLIS

TLIS vs STAG: Complete Analysis 2026

TLISStock

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.

Full TLIS Calculator →

STAGREIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this TLIS vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TLIS vs SCHDTLIS vs JEPITLIS vs OTLIS vs KOTLIS vs MAINTLIS vs PLDTLIS vs EQRTLIS vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.